Stockwinners Market Radar for August 24, 2021 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:31 EDT Monarch Casino COO David Farahi to step down - Monarch Casino announced that Chief Operating Officer David Farahi plans to leave the company, effective September 3, 2021, to pursue business interests outside the gaming and hospitality industry. Monarch also announced that Michelle Shriver has joined the company as Corporate Vice President of Operations. In this role, she will have primary responsibility for the operation of the newly expanded Monarch Casino Resort Spa Black Hawk and will reside in Denver, Colorado. Michelle has been a consultant to the Company since April 2021.

19:48 EDT L3Harris Technologies expands satellite production site - L3Harris Technologies is expanding its satellite production site to include advanced production of unclassified satellites, which will deliver experimental capabilities for national defense. Two of the company's eight buildings have recently been upgraded to manufacture multiple end-to-end satellites per month. L3Harris has built eight satellites at the expanded Palm Bay facility that are currently on orbit and another 10 are in various stages of development. The company plans to add more production capacity by the end of the year to produce six satellites per month.

17:47 EDT Cleveland-Cliffs achieves a total vaccination rate of 75% among employees - Cleveland-Cliffs announced the results of its COVID-19 Vaccination Incentive Program. In July, the Company launched a vaccine incentive program that it developed in partnership with its labor unions, including the United Steelworkers, the United Autoworkers, and the International Association of Machinists. The intent of the Program was to protect the workforce by providing employees with a positive incentive to get vaccinated. Under the Program, the Company committed to pay an employee at least $1,500 to receive a COVID-19 vaccine. For employees at locations with a vaccination rate of 75%, then the Company committed to pay an additional $1,500 to vaccinated employees from that location, representing a total opportunity of $3,000 per employee. The Company achieved a total vaccination rate of 75%, or nearly 19,000 employees out of its workforce of approximately 25,000 employees. Also, 27 of the Company's 43 locations achieved a vaccination rate of at least 75%.

17:45 EDT First American raises quarterly dividend by 11% to 51c per share - The cash dividend is payable on September 15, 2021 to shareholders of record as of September 8, 2021.

17:26 EDT Trustmark to replace Sykes Enterprises in S&P 600 at open on 8/30 - Sitel Group is acquiring Sykes Enterprises (SYKE) in a deal pending final conditions. Trustmark (TRMK) has a market capitalization that is more representative of the small-cap market space.

17:24 EDT Cinemark to replace U.S. Concrete in S&P 600 at open on 8/30 - Vulcan Materials (VMC) is acquiring U.S. Concrete (USCR) in a deal pending final conditions. Cinemark Holdings (CNK) has a market capitalization that is more representative of the small-cap market space.

17:20 EDT BioLife Solutions to replace Saia in S&P 600 at open on 8/30

17:18 EDT Bio-Techne to replace Maxim Integrated in S&P 500 at open on 8/30 - Analog Devices (ADI) is acquiring Maxim Integrated Products (MXIM) in a deal pending final conditions.

17:11 EDT Booz Allen awarded $200M Air Force contract - Booz Allen was awarded a $200M multiple award, indefinite-delivery/indefinite-quantity contract with cost-plus-fixed-fee task orders for research and development. This contract provides for innovative research and development in order to identify, mitigate and protect avionics systems against cyber-attack, and prototype agile, next-generation platform and system of systems architectures to enable rapid integration and fielding of enhanced mission system capability. The location of performance is Beavercreek, Ohio, and work is expected to be completed by August 23, 2028. This award is the result of a competitive acquisition and three offers were received. The Air Force Research Lab is the contracting activity.

16:58 EDT Four Corners Property Trust buys two Pathway Vet Alliance properties for $3.9M - Four Corners Property Trust announced the acquisition of two Pathway Vet Alliance properties for $3.9M. The properties consist of a Thrive Vet Care property and a dual-tenant property that is anchored by Eye Care for Animals and includes a space of approximately 2,000 square feet that FCPT will lease to a new retail tenant. The properties are located in retail corridors in Illinois and Rhode Island and are occupied under net leases with a weighted average term of eight years remaining. The transaction was priced at a 6.6% going-in cash capitalization rate, exclusive of transaction costs.

16:40 EDT Heico sees difficult to predict the Pandemic's path and effect in FY21 and FY22 - The company said, "Looking ahead to the remainder of FY21 and to FY22, we remain cautiously optimistic that the ongoing worldwide rollout of COVID-19 vaccines will positively influence commercial air travel and will benefit the markets we serve. But, as we've all learned, it is difficult to predict the Pandemic's path and effect, including factors like vaccination rates and new variants, which can impact our key markets. Therefore, we feel it would not be responsible to provide fiscal 2021 net sales and earnings guidance at this time. However, our ongoing conservative policies, strong balance sheet, and high degree of liquidity enable us to invest in new research and development, execute on our successful acquisition program, and position HEICO for market share gains as the industry recovers."

16:36 EDT Shopify introduces new in-app shopping experiences on TikTok - Shopify said, in part earlier, in a statement on its blog: "With TikTok Shopping, Shopify is the first commerce platform to bring organic product discovery and shopping tabs to TikTok, helping creators and merchants deepen their relationships with consumers Social commerce represents one of the fastest growing channels for Shopify merchants, especially as more creators rely on these platforms to build their businesses. Today, in partnership with TikTok, we're announcing a new way for entrepreneurs to reach consumers with TikTok Shopping. For the first time, Shopify merchants with a TikTok For Business account will soon be able to add a shopping tab to their TikTok profiles and sync their product catalogues to create a mini-storefront that links directly to their online store for checkout. "I built my business on social media; it's where my fans go first to look for what's new from Kylie Cosmetics," said Kylie Jenner. "I have so much fun creating TikTok videos, and I love sharing posts of my fans using the products. That's why I'm excited for Kylie Cosmetics to be one of the first to let customers shop directly on our TikTok!" "Creators are paving the way for a new kind of entrepreneurship where content, community, and commerce are key," said Harley Finkelstein, President of Shopify. "By enabling new in-app shopping experiences and product discovery on TikTok for the first time, Shopify is powering the creator economy on one of the fastest-growing social and entertainment platforms in the world. We are excited to help this next generation of entrepreneurs connect with their audiences in more ways-and with TikTok as a visionary partner." Reference Link

16:33 EDT Toll Brothers sees Q4 deliveries 3,450 units - Sees Q4 Average Delivered Price per Home of $840,000.

16:31 EDT Toll Brothers reports backlog of $9.44B at Q3-end - Backlog value was $9.44B at third quarter end, up 55% compared to FY 2020's third quarter; homes in backlog were 10,661, up 47%. Quarter-end backlog, in both dollars and units, were all-time records. Net signed contract value was $2.98 billion, up 35% compared to FY 2020's third quarter; contracted homes were 3,154, up 11%. Net signed contracts, in both dollars and units, were third quarter records. Adjusted home sales gross margin, which excludes interest and inventory write-downs, was 25.6%, compared to FY 2020's third quarter adjusted home sales gross margin of 23.9%. SG&A, as a percentage of home sales revenues, was 10.5%, compared to 11.9% in FY 2020's third quarter.

16:24 EDT Graham awarded over $20M in orders to date in Q2 - Graham "announced that it has been awarded over $20M in orders to date in its second quarter of fiscal 2022, which ends September 30, 2021. The orders spanned the company's key defense/space, energy and chemical/petrochemical markets, as well as included advanced energy applications and HVAC. The defense industry awards were $2.6M in orders for both replacement parts of existing programs and new product development for advancing programs serving unmanned undersea vehicles. The company also received $5.2M in awards to support submarine ejection systems. Approximately 40% of the revenue related to the approximately $20M in awards is expected to be recognized in fiscal 2022, which ends March 31, 2022. Approximately 50% of the revenue is expected to be recognized in fiscal 2023 with the remainder expected in fiscal 2024."

16:17 EDT Limoneira falls 16% to $14.25 after below-consensus Q3 pre-announcement

16:15 EDT Proofpoint :U.S. federal jury finds Vade 'maliciously' infringed patents - A U.S. federal jury unanimously found Friday that Vade Secure willfully and maliciously misappropriated over a dozen trade secrets and infringed copyrights belonging to Proofpoint, and its subsidiary Cloudmark LLC, awarding Proofpoint approximately $13.5M in compensatory damages for Vade's unjust enrichment to date. The Court's decision on punitive damages for Vade's willful misappropriation of the trade secrets is expected in late October. Proofpoint will also be seeking injunctive relief to address ongoing and future harm to Proofpoint. The verdict is the culmination of one week of jury deliberations following a three-week trial during which Proofpoint presented evidence of Vade's theft and use of Proofpoint's confidential and proprietary information and source code. Proofpoint successfully demonstrated to the eight jurors that Vade unlawfully took, copied, and used Proofpoint's trade secrets and copyrighted source code as part of several Vade products, including Vade for Microsoft 365, Email Content Filter, Vade Cloud, and Vade MTA Builder. Vade's Chief Technology Officer, Olivier Lemarie, was also found individually liable for trade secret misappropriation, copyright infringement, and breach of his employment agreement with Cloudmark, where he worked before joining Vade in 2017. "Proofpoint invests heavily in R&D to provide innovative and highly effective products to its customers. At the heart of this case was our strong belief that intellectual property rights must be respected," said Gary Steele, CEO & Chairman, Proofpoint. "While we welcome fair competition and collaboration within the cybersecurity community, the misappropriation, copying, and theft of our intellectual property required us to vigorously enforce our rights. We appreciate the jury sending a strong message that the theft of source code and misappropriation of trade secrets is unacceptable."

16:11 EDT Nordstrom reports Q2 ending inventory up 13% vs. 2Q19 - Ending inventory increased 13% compared with the same period in fiscal 2019, versus a 6% decrease in sales. The change in inventory levels versus 2019 was primarily due to the timing shift of the Anniversary Sale and the company's actions to pull forward receipts to mitigate continuing supply chain backlogs and support improving sales trends.

16:10 EDT Nordstrom reports Q2 digital sales up 30% y/y - Digital sales increased 30% compared with the same period in fiscal 2020 and increased 24% compared with the same period in fiscal 2019. The timing shift of the Anniversary Sale had a negative impact on company digital sales of approximately 500 basis points compared with the second quarter of 2019. Digital sales represented 40% of total sales during the quarter.

16:07 EDT Purple Innovation announces departure of CFO Craig Phillips and succession plan - Purple Innovation announced that CFO Craig Phillips and the Company have determined to separate, effective August 31. Purple has engaged an executive search firm to identify Phillips' successor. The Company has appointed Bennett Nussbaum to serve as interim CFO. Nussbaum is a global financial executive and senior adviser with over 45 years of experience including roles as CFO at Pepsi-Cola International (PEP), Burger King and FedEx Office (FDX). Phillips' departure is not related to the Company's operations, financial reporting or controls.

16:04 EDT FSD Pharma terminates FSD-201 Phase 2 Clinical Trial - The company states: "FSD Pharma announced that it intends to terminate the Phase 2 clinical trial of ultra-micronized palmitoylethanolamide , or FSD-201, for use in treating COVID-19. FSD-201 stabilizes mast cells and down-regulates the pro-inflammatory cytokines to effectuate an anti-inflammatory response; it is also known to target the CB2 receptors of the endocannabinoid system of the human body. FSD-201 stabilizes mast cells and down-regulates the pro-inflammatory cytokines to effectuate an anti-inflammatory response; it is also known to target the CB2 receptors of the endocannabinoid system of the human body. The Company has previously successfully completed a Phase 1 first-in-human safety and tolerability study for FSD-201 and the compound to be safe with no serious adverse side effects. In June 2020, the FDA approved the submission of an Investigational New Drug Application for the use of FSD-201 to treat COVID-19 and in September 2020, a randomized, controlled, double-blind, multicenter Phase 2 clinical study was approved by the FDA. The Company is working to complete and publish these findings in the near future."

15:52 EDT PLx Pharma rally attributed to Amazon selling Vazalore aspirin - Shares of PLx Pharma rallied as traders circulated an Amazon listing of Vazalore 325mg, the company's adult aspirin. Amazon lists yesterday, August 23, as the date first available for PLx's Vazalore. Shares of PLx Pharma are up 3% to $17.55 in afternoon trading. Reference Link

14:05 EDT Google unit Waymo debuts autonomous rides in San Francisco - The Waymo (GOOG;GOOGL) Team said , in part in an earlier blog statement: "Today, we're excited to share the next step in our journey in the City by the Bay, with the kickoff of our Waymo One Trusted Tester program. Trusted Tester is a research-focused program that, for the first time, will invite San Franciscans to actively help us shape the future of fully autonomous ride-hailing. We've been driving in the city for over twelve years, have accumulated more autonomous driving miles in California than anyone in the industry, and began ramping up our testing by offering autonomous rides to our employees in San Francisco earlier this year. Now, for the first time, San Franciscans will be able to hail an autonomous ride in one of our all-electric Jaguar I-PACE vehicles equipped with the fifth-generation Waymo Driver. While this is a first for San Francisco, it is a familiar step for Waymo. Over the past four years in Metro Phoenix, we've gone from welcoming our first riders in 2017 with an autonomous specialist on board, to launching the first public, fully autonomous ride hailing service. Since October 2020, we've served tens of thousands of fully autonomous rides, and through our years of experience, have refined our incremental approach guided by our safety framework and rider feedback." Other companies in the autonomous driving space include Uber (UBER), Tesla (TSLA), General Motors (GM), Ford (F), Volkswagen (VWAGY) ,Aptiv (APTV), and Nvidia (NVDA). Reference Link

13:34 EDT Liftoff, Vungle announce definitive agreement to combine - Liftoff, a global performance-based mobile app marketing optimization platform, and Vungle, a global mobile app discovery and enablement platform, announced that they have entered into a definitive agreement to combine. Liftoff co-founder and CEO Mark Ellis will lead the combined company as CEO and Vungle CEO Jeremy Bondy will be assuming the role of President. The transaction follows prior majority investments from private equity funds managed by Blackstone in both Liftoff and Vungle. Blackstone will continue to actively support the combined company as the majority shareholder through this next phase of growth and innovation. The transaction is expected to close at the end of September. Simpson Thacher & Bartlett LLP and Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP served as legal counsel on the transaction.

13:00 EDT Alpha Healthcare reports investor approval of combination with Humacyte - Alpha Healthcare Acquisition Corp. announced that its stockholders voted to approve the previously announced business combination with Humacyte, Inc., a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, and all other proposals presented at AHAC's special shareholder's meeting held on August 24, 2021. AHAC shareholders approved the business combination proposal with 99.5% votes in favor of the approximately 61.6% of AHAC votes cast at the meeting. Subject to the satisfaction or waiver of the other customary closing conditions, the business combination is expected to close on August 26, 2021. Following the closing, the combined company will operate as Humacyte, Inc. and on or about August 27, 2021, its shares of common stock are expected to begin trading on the Nasdaq Global Select Market under the new ticker symbols "HUMA."

12:00 EDT Mister Car Wash falls -7.1% - Mister Car Wash is down -7.1%, or -$1.47 to $19.10.

12:00 EDT Navios Maritime rises 13.6% - Navios Maritime is up 13.6%, or 57c to $4.80.

12:00 EDT Triple-S rises 45.3% - Triple-S is up 45.3%, or $10.96 to $35.15.

11:43 EDT Flora Growth Corporation trading halted, volatility trading pause

11:20 EDT Shopify confirms new in-app shopping experiences on TikTok - Shopify confirmed that it is bringing new in-app shopping experiences to TikTok, saying in a statement: "With TikTok Shopping, Shopify is the first commerce platform to bring organic product discovery and shopping tabs to TikTok, helping creators and merchants deepen their relationships with consumers. Social commerce represents one of the fastest growing channels for Shopify merchants, especially as more creators rely on these platforms to build their businesses. Today, in partnership with TikTok, we're announcing a new way for entrepreneurs to reach consumers with TikTok Shopping. For the first time, Shopify merchants with a TikTok For Business account will soon be able to add a shopping tab to their TikTok profiles and sync their product catalogues to create a mini-storefront that links directly to their online store for checkout. Shopify and TikTok have also partnered to bring product links to Shopify merchants, which can be used to tag products in organic TikTok posts." Reference Link

10:47 EDT Sorrento enters option agreement to exclusively license MPRO inhibitors - Sorrento Therapeutics announced that it has entered into an option agreement with The Texas A&M University System for exclusive rights to the intellectual property covering highly potent main protease inhibitors against SARS-CoV-2. This latest agreement bolsters Sorrento's wide-ranging portfolio of preclinical and clinical therapeutic candidates targeting COVID-19, including new and emerging variants of concern of the SARS-CoV-2 virus. Under the terms of the agreement, Sorrento has an exclusive option to exclusively license patents covering the MPro inhibitor drug candidates. Discovered and developed by Dr. Wenshe Ray Liu and his research team at Texas A&M University, the MPro inhibitors have demonstrated strong cellular antiviral potency against SARS-CoV-2 in preclinical studies. Several MPro inhibitors were identified that exhibited antiviral effects against diverse SARS-CoV-2 variants, including Indian, UK, Brazilian and South Africa variants of concern. The potential advantage of using small molecules, in oral and/or intravenous administration, that target MPro is that they are not affected by mutations in the SARS-CoV-2 spike protein, which may enable MPro drugs to be effective against SARS-CoV-2 and its variants of concern, as well as against other coronaviruses that currently exist or might emerge in the future. Sorrento may exercise its right to enter into a worldwide exclusive license agreement at any time during the option period.

10:18 EDT MyMD Pharmaceuticals announces issuance of new U.S. patent for MYMD-1 - MyMD Pharmaceuticals announced that the United States Patent and Trademark Office has issued U.S. Patent No. 11,096,933 titled "Method of Treating Disorders Associated with Chronic Inflammation." The '933 patent becomes the thirteenth patent protecting the company's lead candidate MYMD-1, a synthetic small molecule being developed to treat autoimmune and age-related diseases, including extending human lifespan, and which has been shown effective in regulating the immune system in preclinical studies, the company said in a statement. "Nearly 100,000 people in the United States have idiopathic pulmonary fibrosis, and although cases continue to climb, there is still a significant unmet need in treatment options for this chronic disease," said Chris Chapman, M.D., President, Director and Chief Medical Officer. "This latest patent underscores MYMD-1's potential to inhibit inflammation, which is linked to myriad diseases including IPF."

10:04 EDT TDK Corporation appoints Jim Tran as CEO, TDK U.S.A. - TDK Corporation (TTDKY) announced the appointment of Mr. Jim Tran to General Manager, Americas HQ and CEO TDK U.S.A. Corporation, effective immediately. Most recently, he was Senior Vice President and General Manager for the Handset Products Business at Qualcomm (QCOM), responsible for Snapdragon chipset and software portfolio. In his new role at TDK, Jim will focus on corporate technology marketing in conjunction with research and development by collaborating with TDK's global HQ's functions such as the corporate technology group, corporate marketing group, and new business incubation teams. Jim will also serve as a Chief Marketing Team Member in the Sensor System Business Company. Mr. Tran will be based on the west coast and supported by Jeffrey Williams, who will remain as TDK U.S.A. Corporation President and DGM of the Americas HQ, responsible for TUC's administrative functions.

10:00 EDT Scor ADR falls -4.8% - Scor ADR is down -4.8%, or -95c to $18.98.

10:00 EDT Ardagh Metal Beverage falls -6.4% - Ardagh Metal Beverage is down -6.4%, or -76c to $11.05.

10:00 EDT Palo Alto Networks rises 16.9% - Palo Alto Networks is up 16.9%, or $63.02 to $435.59.

09:47 EDT Edenor falls -3.8% - Edenor is down -3.8%, or -18c to $4.62.

09:47 EDT Mister Car Wash falls -6.7% - Mister Car Wash is down -6.7%, or -$1.37 to $19.20.

09:47 EDT Palo Alto Networks rises 12.7% - Palo Alto Networks is up 12.7%, or $47.43 to $420.00.

09:28 EDT Healthcare Services pays $6M to settle SEC charges on EPS calculations - Healthcare Services Group announced it has entered into a settlement with the Securities and Exchange Commission , resolving a previously reported investigation into the Company's earnings per share calculations from 2014 to 2017. Under the terms of the settlement, the Company neither admitted nor denied the SEC's charges and agreed to pay a civil monetary penalty of $6.0M. "This settlement reflects our cooperation in working with the SEC to conclude this matter and enables us to continue with the execution of our operational and growth strategies," said Ted Wahl, Chief Executive Officer. "The Company's Board of Directors and management team remain committed to maintaining strong internal controls and adhering to best practices for compliance and corporate governance. We are pleased to put this matter behind us." The Company also announced that John C. Shea, who had served as the Company's Chief Financial Officer since 2012, has been appointed Chief Administrative Officer and will transition to that role effective September 1. In his position as Chief Administrative Officer, Mr. Shea will continue to support the Company's growth initiatives, operational imperative and capital allocation strategy. Andrew Brophy, a Certified Public Accountant, who has served as the Company's SEC Reporting Manager from January 2018 to November 2020, Director of Accounting since November 2020, and Acting Principal Accounting Officer since February , will continue as the Company's Principal Accounting Officer.

09:24 EDT Ocular Therapeutix CEO buys 5K shares of common stock - In a regulatory filing, Ocular Therapeutix disclosed that its CEO Antony Mattessich bought 5K shares of common stock on August 20th in a total transaction size of $49.5K, boosting his stake by about 5%. Shares of Ocular Therapeutix are up 1.9% in pre-market trading at $10.60.

09:17 EDT Natural Alternatives International acquires facility in Carlsbad for $17.5M - Natural Alternatives International (NAII) announced the purchase of a 54,154 ft2 manufacturing and warehouse facility in Carlsbad, CA in a transaction that closed on August 20. This facility is scheduled to be retrofitted to become a dedicated high volume powder blending and packaging facility. This new facility will also provide NAI with additional raw material storage capacity to facilitate anticipated domestic sales growth. NAI purchased this manufacturing facility for $17.5M financed through a $10.0M term loan from Wells Fargo Bank (WFC) and $7.5M of available cash. In connection with this financing transaction, NAI amended its existing credit facility with Wells Fargo to add this new term loan while maintaining a working capital credit line of $20.0M.

09:17 EDT Archer, REEF team up to develop plans for urban takeoff, landing sites - Archer Aviation announced it will work with REEF to develop plans for urban takeoff and landing sites. Archer and REEF will work together to allow Archer's aircraft to access largely dormant rooftop sites across some of the most densely populated and heavily congested urban city locations in the US, including the company's two key launch markets of Los Angeles and Miami. "REEF's network lends itself perfectly to Archer's plans for developing vertiports in dense urban areas. With proximity to high-traffic city hubs, Archer is looking to establish operations in locations that will benefit most from access to the company's planned urban air mobility network," the company said. Using Prime Radiant, the company's proprietary data science technology, Archer will determine optimal landing sites within REEF's existing network. The goal is to identify sites that already have the space needed for takeoff, landing and charging, so minimal construction is required for operations to launch. "Archer is focused on developing urban aerial ridesharing networks that will ease the issues caused by excessive city congestion," said Adam Goldstein, co-Founder and co-CEO of Archer. "We believe that working with REEF will allow us to accelerate our mission to transition congested urban areas to more sustainable forms of transportation. The ability to build out our early vertiports with light retrofitting of existing structures would allow us to scale operations while maintaining our focus on affordability for our customers. We're thrilled to announce this strategic relationship as we continue to execute on our roadmap towards bringing urban air mobility to reality."

09:15 EDT Noodles & Company enters franchise agreement to expand in Texas, New Mexico - Noodles & Company announced that it has entered into a multi-unit franchise and area development agreement with Carlos Hill, the President of Tsunami Enterprises, LLC. Four new Noodles & Company restaurants are planned for the El Paso & Las Cruces metropolitan area during the next three years, with the first scheduled to open its doors by the Fall of 2022.

09:14 EDT Ebang announces results of mediation on a sales contract dispute - Ebang International Holdings announced the results of a mediation related to a dispute from a sales contract with one of its customers. As disclosed in the Company's recent annual report filed with the Securities and Exchange Commission, on November 22, 2019, the Company brought a claim in the Hangzhou Intermediate People's Court against one of its customers and the ultimate beneficial owner of the mining machines in connection with its sales of 80,000 mining machines. On August 23, 2021, an agreement between the Company and the defendants Zhejiang Qirui Machinery Equipment, Zhejiang Huatie Emergency Equipment Science &Technology, and Mr. Danfeng Hu, the President and CEO of Huatie Emergency, was reached and has come into effect following a mediation by the court. The result of mediation is as follows: All parties confirmed that the Company has delivered 80,000 mining machines involved in this case, of which 24,000 mining machines have been paid for. The rest of 56,000 mining machines will be paid by Niubo in the amount of RMB272 million. On August 20, 2021, Niubo paid RMB20 million. Niubo will pay the remaining in installments as follows: RMB10 million by September 15, 2021, RMB76 million by December 31, 2021, RMB136 million by May 30, 2022, and RMB30 million by July 31, 2022. If Niubo fails to make the payment in full and on time in any such installment, the Company has the right to directly apply to the People's Court for enforcement of all the outstanding payments and liquidate damages of Niubo. Kabayi assumes joint and several liabilities for all the aforementioned debts of Niubo. All parties confirmed there is no other disputes related to this sales contract. Qirui and Niubo released and discharged the Company of and from any and all liabilities and claims related to the sale of the mining machines.

09:13 EDT ORBCOMM selected by WEL Companies to provide tracking, monitoring solutions - ORBCOMM announced that it has been selected by WEL Companies to provide its integrated dry and refrigerated trailer tracking and monitoring solutions, driving efficiencies across their supply chain operations. ORBCOMM's solutions provide wireless connectivity through its hardware and a single, unified Cloud-based analytics platform for optimal fleet management across multiple asset classes. WEL is also deploying ORBCOMM's trailer tracking solution, which features a high-sensitivity solar panel with long-lasting battery life and charging capabilities, gaining complete visibility and control over their mixed fleet. ORBCOMM's solution enables WEL to access live and scheduled status updates whether their trailers are in transit or in the yard, so they always know where their trailers are located and if they are empty or loaded, improving turn times and yard management, while saving their drivers time and fuel. In addition, WEL is utilizing ORBCOMM's detention monitoring feature to improve billing accuracy and driver productivity, creating a more effective supply chain. WEL has started installing ORBCOMM's telematics solutions across their fleet and expects to complete their deployment by the end of 2021.

09:11 EDT Siemens to support electric vehicle infrastructure with VersiCharge - Siemens is announcing its commitment to invest and expand the company's U.S. manufacturing operations to support electric vehicle infrastructure in America. The company will bolster its existing manufacturing footprint of EV infrastructure with the VersiCharge Level 2 AC series product line of commercial and residential EV chargers. With this addition, Siemens is preparing to manufacture over 1M electric vehicle chargers for the United States over the next four years. This investment is the latest in the company's strategic plan to meet accelerating electric vehicle charging demand, expand its manufacturing capabilities, and increase transportation electrification job opportunities at all levels in the United States. The company is currently conducting local site evaluations. The new facility will be the company's third U.S. eMobility hub and is projected to support 100 jobs across the manufacturing site and regional supply chain. Siemens plans to identify a location this year and bring a facility online to begin manufacturing AC chargers in the United States in early 2022.

09:09 EDT Sumo Logic announces availability of Sumo Logic Cloud SOAR - Sumo Logic announced the general availability of Sumo Logic Cloud SOAR, the latest offering in its cloud-native security intelligence portfolio that modernizes organizations' Security Operations Center. Sumo Logic Cloud SOAR - Security Orchestration, Automation and Response - improves SOC productivity, increases visibility, enhances incident response and helps security professionals make insightful decisions. Sumo Logic Cloud SOAR is available now and integrates seamlessly with over 200 third-party security and IT tools and natively with Sumo Logic solutions.

09:08 EDT Comtech awarded $6.3M in contracts for high-power Ka-Band TWTAs - Comtech Telecommunications announced , that during its fourth quarter of fiscal 2021, it was awarded multiple contracts aggregating $6.3M for 500W Ka-band traveling wave tube amplifiers, TWTAs, for both military and commercial High-throughput Satellite systems. HTS systems offer the high speed of fiber with the reliability, global coverage and flexibility of a satellite architecture. Military and commercial customers demand high-capacity data rates with fiber-like connectivity. "Comtech's 500W family of Ka-band TWTAs provide the power needed for these high-capacity connections," said Fred Kornberg, Chairman of the Board and Chief Executive Officer of Comtech Telecommunications Corp. "Working with Ka-band HTS system integrators and satellite operators, Comtech provides the power amplifier solutions they need."

09:07 EDT GoDaddy announces new feature, GoDaddy Invoicing and Payments - GoDaddy announced GoDaddy Invoicing and Payments, a new feature in the Hub by GoDaddy Pro which enables easier and faster invoicing processing solutions for web designers and developers through a simple integrated user interface. This new innovation was made possible through technology acquired via the Poynt acquisition made in December 2020. Collecting online payments is one of the top requested features from Pros and with limited alternatives in the market, GoDaddy Invoicing and Payments removes the need for third party tools to manage and create invoices. GoDaddy customers can save time by managing all of their accounts and invoices in one place. GoDaddy Invoicing and Payments allows customers to create and send an invoice for free, with a small per-transaction fee to collect payments online with GoDaddy Payments. This feature goes live to a limited United States based subset of the GoDaddy Pro audience in August and will be expanded to more customers over time.

09:06 EDT CynergisTek unit Backbone Consultants in pact with life insurance company - Backbone Consultants, a division of CynergisTek announced a new agreement with a Top 10 life insurance company, with more than $90Bin assets to provide IT audit co-sourcing services. Financial industries use audits for a number of important business and compliance requirements from ensuring there is an effective governance structure to assessing the effectiveness and efficiency of IT controls and internal processes. CynergisTek's audit services are designed to measure organizations against HIPAA, GLBA, SOX, GDPR, PCI, and general IT audit principles.

09:05 EDT Olo and 5&5 announce partnership - 5&5, the restaurant consulting arm of Tijoh, a multidisciplinary portfolio company operating in the digital space, has announced an official partnership with Olo. 5&5 is the restaurant industry's premier solution for implementation, support, and strategic growth for enterprise SaaS solution platforms. This partnership allows brands to expand their restaurant corporate support team with the team at 5&5 to drive best-in-class solutions with Olo.

09:05 EDT Rackspace Technology launches Rackspace Elastic Engineering for Security - Rackspace Technology announced the launch of Rackspace Elastic Engineering for Security. The breakthrough security offering transforms cloud security operations by offering customers access to a pod of experts who work as an extension of internal staff to address complex cybersecurity and compliance challenges. Rackspace Technology is the only provider in the market offering a cloud-like way to consume security expertise and technology. Rackspace Elastic Engineering for Security encompasses security expertise in the areas of cloud migration, securing apps and data in the cloud, as well as ongoing management and support services. With the security landscape and array of threats constantly evolving, businesses require modern security services that align with agile, cloud-first operating models.

09:03 EDT Nvidia announces availability of NVIDIA AI Enterprise - NVIDIA announced the availability of NVIDIA AI Enterprise, a comprehensive software suite of AI tools and frameworks that enables the hundreds of thousands of companies running VMware vSphere to virtualize AI workloads on NVIDIA-Certified Systems. Manufacturers Atos, Dell Technologies, GIGABYTE, Hewlett Packard Enterprise, Inspur, Lenovo and Supermicro are offering NVIDIA-Certified Systems optimized for AI workloads on VMware vSphere with NVIDIA AI Enterprise. Separately, Dell Technologies announced Dell EMC VxRail as the first hyperconverged platform to be qualified as an NVIDIA-Certified System for NVIDIA AI Enterprise.

09:02 EDT Sophia Genetics and Dasa expand partnership to offer HRD analytics solution - Dasa, the largest integrated healthcare network in Brazil, expanded its partnership with SOPHiA GENETICS to offer the first decentralized HRD, or Homologous recombination deficiency, analytics solution in Latin America. HRD is a complex biomarker, important for PARP inhibitors, that helps identify whether cancer patients may respond better to specific treatments, and its use could ultimately lead to personalized therapies that benefit the individual patient. Renowned in Brazil and abroad, Dasa serves more than 20M patients per year

09:02 EDT Superior Energy announces appointment of Spexarth as EVP, CFO, Treasurer - Superior Energy Services announced its board of directors has appointed James Spexarth to serve as the Company's Executive Vice President, or EVP, Chief Financial Officer, or CFO, and Treasurer, effective August 19, 2021. Spexarth has been serving as interim Chief Financial Officer since March 18, 2021 following the resignation of the previous Chief Financial Officer, Westervelt Ballard. Spexarth has been employed by the Company for 8 years and served as the Company's Chief Accounting Officer and previously served as vice president and corporate controller.

08:47 EDT Camber Energy unit in intellectual property license pact with ESG Clean Energy - Camber Energy announces its majority-owned subsidiary, Viking Energy Group entered into an Exclusive Intellectual Property License Agreement with ESG Clean Energy regarding ESG's patent rights and know-how related to stationary electric power generation, including methods to utilize heat and capture carbon dioxide . The license is exclusive for all of Canada and non-exclusive for up to twenty-five locations in the United States.The ESG Clean Energy System is designed to generate clean electricity from internal combustion engines and utilize waste heat to capture 100%of the carbon dioxide emitted from the engine without loss of efficiency, and in a manner to facilitate the production of precious commodities ammonia for sale. James Doris, President and Chief Executive Officer of Camber, commented, "In my view this transaction positions us as an industry leader in terms of being able to assist with the power generation needs of commercial and industrial organizations while at the same time helping them reduce their carbon footprint to satisfy regulatory requirements or to simply follow best ESG-practices. We are excited to be able to use the platform of Simson-Maxwell Ltd., our recently acquired majority-owned subsidiary, to promote the ESG Clean Energy System."

08:42 EDT BK Technologies receives purchase order from NIFC for BKR 5000 technology - BK Technologies announced that it has received a purchase order from the National Interagency Fire Center, or NIFC, Radio Cache for its new BKR 5000 portable communications technology. The National Interagency Incident Communications Division Radio Cache is the wildland fire community's national radio and repeater cache. With 11,000 handheld radios, 300 repeaters, and other communications equipment, it is arguably the largest civilian radio cache in the world and can support about 32,000 firefighters or more than 50 major disasters at one time.

08:40 EDT AGM Group Holdings announces strategy of blockchain business - AGM Group Holdings announced its growth strategy mainly focusing on crypto miner business and high-performance ASIC chip research and development, and supplemented by development of blockchain and fintech applications. AGMH has assembled a team of industry veterans in high-performance chip designs and blockchain applications to support its growth strategy. In implementing the strategy, AGMH's fintech product team remains actively researching and seeking opportunities to introduce blockchain-based NFT and Defi technologies into existing products and services, aiming to provide more values to clients.

08:40 EDT AFC Gamma provides DMA Holdings with $19.75M credit facility - AFC Gamma announced it has provided a credit facility of $19.75 million to DMA Holdings MA, a single-state Massachusetts operator. The credit facility is designed to provide DMA with the capital necessary to purchase and expand its Tier 6 cultivation license, as well as complete the buildout of its processing facility and dispensary in Dudley, Massachusetts. AFC will hold the entire $19.75 million credit facility, which consists of a first-lien term loan. The loan is secured by first-lien mortgages on DMA's wholly owned real estate properties in Massachusetts and other commercial-security interests. AFC Management, LLC served as Lead Arranger and Administrative Agent for the transaction.

08:39 EDT iSun awarded $7.2M in portfolio of EPC projects in New Hampshire - iSun announced that it has been awarded a portfolio of projects for Engineering, Procurement and Construction services in the state of New Hampshire. iSun estimates that the five-project portfolio will have a combined contract value exceeding $7.2M with four projects commencing prior to the end of 2021. These awards are an important milestone for iSun, for several reasons," said Jeffrey Peck, Chairman and Chief Executive Officer of iSun. "For our investors, this growth reflects the progress we've steadily been making against our three-pronged strategy for growth. Since first announcing this strategy in late 2019, we've maintained that our relationships and reputation within regions where we're more established will provide springboards for continued growth opportunities. These contracts are proof of exactly that." "Similarly, as recently as last week, we provided guidance suggesting that iSun would double revenue in 2021," continued Peck. "The award of these projects moves us closer to these targets."

08:37 EDT Danaher: Christopher Bouda to succeed Robert Lutz as Chief Accounting Officer - The company announced that Christopher Bouda will succeed Robert Lutz as Chief Accounting Officer of Danaher, effective January 1, 2022, reporting to Matthew McGrew, Danaher's Executive Vice President & CFO. Bouda is currently Vice President, Finance for Danaher. Lutz will continue to work with the company on a part-time basis until his retirement in the fourth quarter of 2022.

08:37 EDT Color Star Technology subsidiary signs agreement with Shaquille O'Neal - Color Star Technology announced the signing of a cooperation agreement between Color China Entertainment, a wholly-owned subsidiary of Color Star, and Shaquille O'Neal, also known as "Big Shark", a world-class basketball player and NBA Hall of Fame star. The two parties formally reached an agreement on March 29 for Shaquille O'Neal to become a celebrity instructor on the entertainment sharing and interactive platform of Color Star, known as Color Star APP. He will teach basketball-related content online, as well as share his experiences as a basketball star. The cooperation between Color Star and O'Neal is a prelude to collaboration between the Color Star APP and sports stars. As an internationally recognized basketball superstar, O'Neal will be able to attract more fans to the Color Star APP, and as a celebrity entertainment interactive platform, Color Star will encompass celebrities in the entertainment industry as well as in the sports arena. In the future, Color Star APP will have opportunities for in-depth collaboration with more celebrities in other industries.

08:36 EDT Avant Brands joins NASDAQ-listed Cannabis ETF - Avant Brands announces that it has been added to the Global X Cannabis ETF, which is listed on the NASDAQ exchange. The Global X Cannabis ETF seeks to invest in companies across the cannabis industry. This includes companies involved in the legal production, growth and distribution of cannabis and industrial hemp, as well as those involved in providing financial services to the cannabis industry, pharmaceutical applications of cannabis, cannabidiol, or other related uses including but not limited to extracts, derivatives, or synthetic versions.

08:34 EDT PlayMonster expands partnership Hasbro - PlayMonster announced that it has expanded its partnership with Hasbro by entering into a deal with Playskool, that will see PlayMonster strategically grow its preschool category in 2022 and beyond. Both companies will work together to expand and broaden the iconic Playskool brand, bringing new ways to learn and play within the Playskool portfolio, while reimagining Playskool's most beloved, nostalgic brands to engage millennial parents and a new generation of kids. PlayMonster Playskool brands will be widely available across retail, starting early 2022.

08:33 EDT GrowGeneration acquires Commercial Grow Supply, terms not disclosed - GrowGeneration announced its acquisition of Commercial Grow Supply, a hydroponic superstore located in Santa Clarita, California. Founded in 2011 by Sevan Derohanian, Commercial Grow Supply is one of the largest hydroponic suppliers in Los Angeles County, with annual revenues approaching $10M. The acquisition brings the number of GrowGen locations in California, the country's largest legal cannabis market, to 22, with 10 locations in Southern California. The Commercial Grow Supply acquisition is GrowGen's 14th this year and follows yet another quarter of record earnings. The Company raised its 2021 revenue guidance to $455M-$475M, consensus $468.58M. GrowGen plans to have over 70 garden center locations by the end of 2021.

08:30 EDT Finning International appoints Dave Primrose as interim CHRO - Finning International announced the following changes to its leadership team, effective immediately. Tim Ferwerda, currently the Director of Sales, Marketing and Distribution in the UK & Ireland, has stepped into the role of Managing Director for our UK & Ireland business. Managing Director for the UK & Ireland, Dave Primrose, has taken on the role of interim Chief Human Resources Office, as our current CHRO Chad Hiley has resigned from his position for personal reasons. Dave has deep experience in both operations and HR at Finning, including time as our CHRO, and we are confident in his ability to lead the team as we search for a new candidate for this role.

08:26 EDT Oramed enrolled 25% of patients planned for Phase 3 ORA-D-013-2 trial - Oramed Pharmaceuticals announced that it has enrolled and randomized over 25% of the planned 450 patients for its Phase 3 ORA-D-013-2 trial of its oral insulin capsule ORMD-0801 for the treatment of type 2 diabetes, or T2D. ORA-D-013-2 is the second of Oramed's two Phase 3 trials being conducted under FDA approved protocols to treat T2D patients who have inadequate glycemic control over a period of 6 to 12 months. The concurrent trial, ORA-D-013-1, completed enrollment and randomization of nearly 65% of its 675 planned patients and is on track to complete randomization with topline results expected in 2022. The ORA-D-013-2 study is recruiting 450 T2D patients with inadequate glycemic control who are managing their condition with either diet alone or with diet and metformin monotherapy. Patients are being recruited through 28 sites in the U.S. and 25 sites in Western Europe and Israel. The double-blind study will randomize patients 1:1 into two cohorts dosed with 8 mg of ORMD-0801 at night and placebo at night

08:22 EDT Velodyne Lidar responds to David Hall's open letter to the board - "Velodyne Lidar responded to the latest false statements contained in David Hall's August 23 open letter to the Company's Board of Directors . The Company believes that this latest missive from David Hall is part of an ongoing, self-serving and deceptive campaign in which he has used false statements to disparage the Company's Board and distract attention from his own repeated pattern of misconduct. This misconduct dates back to Mr. Hall's failure to operate with respect, honesty, integrity, and candor in his dealings with Company officers and directors, resulting in his censure and removal as Chairman of the Board...The Company continues to innovate on its cutting-edge, award-winning products to advance its strong pipeline and meet demand for its revolutionary hardware and software solutions. David Hall is Attempting to Divert Attention from the Ongoing Arbitration Regarding his Theft of Confidential Intellectual Property The Company believes that Mr. Hall's actions are an attempt to distract from the serious and ongoing arbitration against Mr. Hall regarding his theft of Velodyne's confidential, trade secret information. Mr. Hall has never denied taking this confidential, trade secret information, which he seems intent upon using to further his personal business ventures to the detriment of Velodyne and its stockholders. Michael Dee and Hamid Zarringhalam are independent directors focused on the long-term success of the Company, who have exceptional track records of success as business leaders and have served as outstanding stewards of Velodyne and its stockholders," said the company in a statement.

08:19 EDT FactSet appoints Linda Huber as Chief Financial Officer - FactSet announced the appointment of Linda Huber as Chief Financial Officer. She will join FactSet in early October 2021. Huber brings over 30 years of experience in the financial services industry, including 15 years as a public company CFO. As CFO, Huber will lead FactSet's global finance organization and oversee all financial functions, including accounting, corporate development, financial planning and analysis, treasury, tax, and investor and media relations. She will report to Phil Snow, FactSet's Chief Executive Officer.

08:18 EDT Oportun Financial nearly doubling its addressable market - Oportun announced that it can now offer personal loans in 24 total states, up from the 12 the company was operating in just yesterday. The significant expansion makes Oportun available to consumers in Arkansas, Delaware, Indiana, Kentucky, Mississippi, Montana, North Dakota, New Hampshire, Oregon, South Carolina, South Dakota, and Virginia. "Using A.I. and alternative data, Oportun has a proven ability to serve consumers who are locked out of the financial mainstream because of limited credit history," said Raul Vazquez, CEO of Oportun. "With an estimated 100M adults in the U.S. with no credit score or who have been mis-scored, the impact is felt in nearly every community across the United States, and Oportun is moving with urgency to help solve this problem at scale." Oportun has successfully provided more than 4.3M loans and $10.5B in credit, primarily in small dollar loans. By reporting repayment performance to the major credit bureaus, the company has also helped more than 925,000 people begin to establish a credit history.

08:16 EDT Timber announce last patient visit in Phase 2b CONTROL study for TMB-001 - Timber Pharmaceuticals announced that the last patient completed their last visit in the Phase 2b CONTROL study evaluating TMB-001, a topical isotretinoin formulated using Timber's patented IPEG delivery system, in patients with moderate to severe subtypes of congenital ichthyosis. The IPEG delivery system was designed to maximize isotretinoin delivery into pathologic skin layers, while minimizing systemic absorption. "It is important to thank the clinicians and patients who have participated in the CONTROL study and allowed us to make such rapid progress to the completion of the last patient visit," said Alan Mendelsohn, M.D., Chief Medical Officer of Timber. "With this important milestone we are now one step closer to reporting topline data from the study and moving forward with Phase 3 trial planning."

08:15 EDT Sight Sciences publication of two-year outcomes for OMNI surgical system - Sight Sciences announced publication in Clinical Ophthalhmology of favorable 24-month outcomes from a single center open-label study of the OMNI Surgical System conducted in Germany. OMNI is cleared by the Food and Drug Administration and CE-Marked for canaloplasty followed by trabeculotomy to reduce intraocular pressure in adult patients with primary open-angle glaucoma and open-angle glaucoma. Sight Sciences intends to further develop OMNI, and to seek regulatory clearance, for expanded indications. Results from the study, conducted and co-authored by Karsten Klabe, M.D. and Hakan Kaymak, M.D., report that use of OMNI to perform a standalone MIGS procedure in mild to moderate open-angle glaucoma resulted in statistically significant reductions in both IOP and IOP-lowering medication use at 24 months. The study included long-term outcomes from 38 eyes of 27 subjects with open-angle glaucoma. Mean baseline IOP in the study decreased from 24.6 mmHg preoperatively to 14.7 and 14.9 mmHg at months 12 and 24, respectively, reductions of approximately 10 mmHg or approximately 40%. All subjects in the study, and 100% of eyes, had at least a 20% IOP reduction at 24 months. Mean baseline IOP-lowering medication also decreased from 1.9 average medications per patient to 0.5 medications at month 24. At 24 months, nearly 60% of eyes were free of IOP-lowering medication. Both IOP and IOP-lowering medication reduction outcomes in the study were statistically significant. "These results are particularly meaningful because they support the long-term benefits of OMNI for use in a standalone procedure, regardless of lens status, to reduce IOP and the burden of medication in adult patients with POAG," said Paul Badawi, Co-Founder and CEO, Sight Sciences. "We believe that OMNI uniquely enables clinicians to perform two implant-free procedures to address all three points of resistance in the diseased conventional outflow pathway with a single device through a single clear corneal microincision. We believe that these results may support OMNI's potential for expanded indications in other glaucoma patient populations."

08:11 EDT Unity Software acquires OTO acoustic intelligence platform - Unity announced the acquisition of OTO, an AI-driven acoustic intelligence platform that can be leveraged to build and foster safer gaming environments with voice and text chat environments. OTO will be integrated into Unity's Vivox platform as a cornerstone for solving one of gaming's global challenges: the rise of toxic behavior that leads to poor player experience, and ultimately, lost revenue for game creators. The transaction closed on August 12. Financial and legal terms of the deal will not be disclosed.

08:10 EDT NMI Holdings's National Mortgage Insurance integrates mortgage coach - National Mortgage Insurance, the primary operating subsidiary of NMI Holdings, is now integrated with the Mortgage Coach platform, which enables mortgage lenders to create accurate, digital home loan comparison scenarios for borrowers. Mortgage lenders use the Mortgage Coach platform to share multi-option loan comparisons with borrowers through an interactive Total Cost Analysis, or TCA, presentation. Each personalized TCA presentation is delivered via a digital link, enabling the borrower to compare loan scenarios and pricing to make a more informed mortgage decision. Borrowers can now instantly view a side-by-side comparison of loan options, which include National MI mortgage insurance product options, to clearly understand the impact of private MI and the additional affordability it can provide over the life of the mortgage loan.

08:09 EDT Wipro to invest $3M to open new delivery center in Arkansas - Wipro announced that it will open a new delivery center in Sherwood, Arkansas. The company expects to hire up to 400 employees in the next two years in Arkansas. Wipro will invest approximately $3M to transform a 70,000 square-foot facility at Landers Road into a customer service center. The delivery center will provide operational services to Wipro's clients across industry verticals.

08:08 EDT NV5 Global acquires Sage Renewable Energy Consulting - NV5 Global announced that it has acquired Sage Renewable Energy Consulting. Sage operates nationwide and expands NV5's growing environmental, social, and governance service portfolio. The acquisition was made with a combination of cash and stock and will be immediately accretive to NV5's earnings. "Clean energy continues to grow as a percentage of NV5's revenue," said Dickerson Wright, PE, Chairman and CEO of NV5. "Sage's expertise in the renewables, battery storage, microgrid, and electric vehicle planning space enhances our ESG capabilities and presents opportunities for cross-selling with our existing ESG services."

08:07 EDT SuperCom subsidiary selected for juvenile program in California - SuperCom announces that through its fully-owned subsidiary, Leaders in Community Alternatives, or LCA, it has won a new project in California to provide Juvenile Programing and Rehabilitative Services for out-of-custody juvenile programming. This project supports those reentering the community from periods of incarceration by providing evidence-based and individualized services that contribute to a reduction in recidivism. This new project is valued at up to $240,000 per year, starting with an initial evaluation term of one year. After the first year, the government agency will consider expanding the project with a longer-term scope. The project has already launched and is currently servicing clients in this county.

08:07 EDT Ortelius Advisors issues letter to Capital Senior Living stockholders - Ortelius Advisors issued the below open letter to stockholders of Capital Senior Living. The letter said, "Ortelius Advisors, L.P. (together with its affiliates, "Ortelius" or "we") is one of the largest stockholders of Capital Senior Living Corporation ("Capital Senior Living" or the "Company"). We have continued to demonstrate our significant confidence in Capital Senior Living's assets, operations and long-term potential by recently increasing our stockholdings from 7.2% to 12.7%. As the pandemic subsides and industry fundamentals continue to improve, Ortelius firmly believes the Company can become a source of enduring value. This is why we vehemently oppose the Board of Directors' (the "Board") decision to enter into a series of exceedingly costly and highly-dilutive transactions (the "Transactions") that would also effectively hand over control of the Company to Conversant Capital LLC and its affiliates (collectively "Conversant"). As it stands, the Board has given away any right to consider alternative and superior proposals - including from stockholders such as Ortelius - until the Transactions are voted down. This is why Ortelius intends to vote AGAINST each of the Company's proposals at the upcoming Special Meeting of Stockholders (the "Special Meeting"). If stockholders vote down the egregious Transactions, we believe the Board will be in a position to receive and solicit alternative financing proposals that are superior to the one put forth by Conversant. In the days to come, Ortelius expects that Capital Senior Living will attempt to attack our analysis and argue that the Transactions with Conversant are in your best interest. We also suspect the Company will claim it exhaustively explored strategic alternatives and evaluated other financing options, and that Conversant provided the best terms available to avert an imminent liquidity crisis. We urge you to look past those claims and focus on the facts. In our view, stockholders should be focused on the following when considering whether or not to support the Transactions: The Board's seemingly flawed and inadequate process for assessing the Company's capital needs and entering into the agreement with Conversant. The gross misalignment between the Company's existing stockholders and its management, bankers and Conversant. The Board's lengthy track record of poor oversight and value-destructive decisions... Reinforced by the arguments laid out in this letter and our previous communication to the Board, we plan to vote AGAINST all of the proposals at the Special Meeting. Ortelius does not believe that Capital Senior Living faces an immediate need for the usurious financing offered by Conversant and is confident that the Board could have obtained a different transaction with superior terms. There remain ample opportunities for the Board to fulfill its fiduciary responsibilities to stockholders, including by credibly assessing alternative strategic and financing options that would benefit all equity holders. We hope stockholders can force the Board to explore those opportunities by voting down the Transactions."

08:06 EDT Peloton Tread to be available in U.S., Canada and U.K. - Peloton announced the all new Peloton Tread will be available in the U.S., Canada, and the United Kingdom August 30, and will be available in Germany in fall 2021. The new Peloton Tread combines Peloton's award-winning content and quality design with safety features integrated into the experience to create an efficient and engaging total body workout experience.

08:04 EDT TransUnion launches TruAudience marketing solutions - TransUnion unveiled the launch of its TruAudience solutions to provide a foundation of trust on which businesses build future-proofed identity and data capabilities. With insight into 98% of U.S. adults and more than 127 million homes, including 80 million connected homes, TruAudience delivers the scale, accuracy, speed, connectivity and trust that marketers, media companies and technology providers need to engage consumers across the evolving media landscape. TruAudience is the culmination of 2.5 years building a robust suite of identity, addressability and data solutions. It integrates the technology and expertise from three acquisitions TransUnion completed throughout 2019 and 2020, including Tru Optik, Signal Digital and TruSignal. TruAudience includes three core offerings: TruAudience Identity, TruAudience Data Marketplace and TruAudience Platform. Each offering is made available directly to marketers and advertisers or through industry partnerships.

08:04 EDT AMC Networks announces CEO to transition to executive vice chairman - AMC Networks announced that following a successful 26-year tenure as president and chief executive officer Josh Sapan has notified the company of his desire to transition to executive vice chairman. To help ensure an orderly transition, the company also announced that seasoned media executive Matthew Blank will serve as interim chief executive officer while the company conducts a search for a replacement. Over more than three decades, Sapan grew AMC Networks into a global entertainment company known for celebrated and original content. In his new role as executive vice chairman, Sapan will continue to assist in setting AMC Networks' corporate and creative direction and work closely with the company's leadership to support the overall advancement of the company, particularly as it continues to grow its targeted streaming business. Blank joins AMC Networks following more than 40 years of leadership positions in the media industry, including 20 years as chairman and chief executive officer of Showtime Networks, where he also served as president and chief operating officer. While at Showtime, As interim chief executive officer, Blank will utilize his expertise and work with AMC Networks' leadership, including Sapan, to maximize the company's streaming business, while building on its core assets.

08:03 EDT electroCore announces reseller agreement with Red One Medical Devices - electroCore announced a reseller agreement with Red One Medical Devices. The partnership will further expand availability of electroCore's gammaCore platform in the federal marketplace. Red One is a Service-Disabled Veteran-Owned Small Businessoffering medical and pharmaceutical goods and services to the U.S. Department of Veterans Affairs and Department of Defense hospitals, ensuring compliance with contracting regulations, and providing logistical solutions connected directly into government contracting portals such as ECAT, GSA, DAPA, BPA, and DIBBS.

08:02 EDT Roche, Shape Therapeutics enter research collaboration for RNA editing tech - Shape Therapeutics announced a multi-target strategic collaboration and license agreement with Roche. Through this partnership ShapeTX will apply its proprietary RNA editing platform RNAfix and potentially leverage its AAVid technology platform for next-generation tissue-specific adeno-associated viruses for the development of gene therapy for certain targets in the areas of Alzheimer's disease, Parkinson's disease, and rare diseases. During the course of the partnership, ShapeTX will conduct preclinical research to identify and deliver development candidates discovered by its AI-powered platforms RNAfix and, potentially, AAVid. Roche will be responsible for the development and worldwide commercialization of any potential products resulting from the collaboration. Under the terms of the agreement, ShapeTX is eligible to receive an initial payment as well as development, regulatory and sales milestone payments, potentially exceeding $3 billion in aggregate value. ShapeTX is also eligible to receive tiered royalties on future sales of products resulting from the collaboration.

08:01 EDT Bed Bath & Beyond names Nicole Cokley Dunlap as Chief Diversity Officer - Bed Bath & Beyond announced that it has named Nicole Cokley Dunlap as its Chief Diversity Officer, who will lead the Company's diversity, equity and inclusion strategy. Ms. Cokley Dunlap brings more than 25 years of expertise to her role and will report directly to Lynda Markoe, EVP and Chief People and Culture Officer. She will begin in her new role in September. Cokley Dunlap comes to Bed Bath & Beyond from Macy's, where she held roles with increasing levels of leadership responsibilities across Bloomingdale's and Macy's Inc. in human resources, employee giving, diversity and inclusion, and store management. She served as Vice President of Diversity & Inclusion Strategy since 2019 and built strategies that helped drive diversity, engagement, performance, and business growth. Before that, she was Bloomingdale's Vice President, Diversity & Inclusion, Employee Giving and Human Resources Business Partner. Ms. Cokley Dunlap also serves as Co-President of BRAG, a non-profit organization that prepares and educates people of color for executive leadership roles in retail, fashion and related industries.

07:49 EDT Huazhu Group vice-chairlady Min Zhang resigns - Min Zhang resigned as a director and the vice-chairlady of the Company for personal reasons, effective August 24, 2021. Ms. Zhang's resignation from the board of directors was not a result of any disagreement with the Company on any matter related to the operations, policies, or practices of the Company. Upon the effectiveness of Ms. Zhang's resignation, the Company's board of directors will consist of eight directors, including five independent directors.

07:39 EDT Ayr Wellness adds to Florida retail footprint, opens new dispensary - Ayr Wellness announced the opening of Liberty Health Sciences Boynton Beach, the Company's 40th operating dispensary in Florida. The Boynton Beach dispensary is located at 1865 W Woolbright Road, Boynton Beach, Florida, 33426. The 1,600 sq. ft. retail store sits within a shopping center with approximately 60 parking spaces and is a 10-minute drive from some of South Florida's beaches. Jonathan Sandelman, CEO of Ayr, said, "With 40 open stores in Florida, we now have the second largest retail footprint in the state, with more set to open during the rest of the year. Our plan in Florida is working. Our improved cultivation facility is allowing us to open new stores at a rapid clip and is helping to greatly expand our presence in what is quickly becoming one of the largest marijuana markets in the U.S. As we continue to improve our product mix, Ayr will increasingly become a force to be reckoned with in the Florida market."

07:37 EDT HCW Biologics showcases scientific paper on HCW9218 - HCW Biologics announced the publication of a scientific paper, authored by the Company's scientific research team in the peer-reviewed journal, Molecular Therapy. Entitled, "Bifunctional TGF-beta trap/IL-15 Protein Complex Elicits Potent NK Cell and CD8+ T Cell Immunity Against Solid Tumors," the paper highlights preclinical data from in vivo studies demonstrating the potential of the Company's lead investigational candidate, HCW9218, as a novel immunostimulant with the ability to simultaneously lessen immunosuppression in patients with cancer. As detailed in the paper, preclinical data demonstrated that HCW9218, administered as a monotherapy, was well tolerated and showed potent anti-cancer activity in animal models of melanoma. The data showed limited side effects, with none of the bleeding episodes often associated with high doses of other antibody-based TGF-beta neutralizers. HCW9218 showed an ability to promote proliferation and metabolic activity of immune cells as well as enhance the cells' cytotoxicity with tumor targets. Importantly, we presented data from mouse animal models in melanoma which demonstrated that HCW9218 slowed tumor growth and prolonged survival in mice treated with HCW9218 as a monotherapy. This antitumor activity was mediated by immune cells and correlated with increased immune cell infiltration into tumors. HCW Biologics expects to submit an Investigational New Drug application to the U.S. Food and Drug Administration for a Phase 1b/2 clinical trial to evaluate HCW9218 in chemotherapy-refractory pancreatic cancer by year-end 2021. The Company is in the final stages of IND-enabling activities.

07:34 EDT Aehr Test Systems receives $3M in orders to support silicon carbide test - Aehr Test Systems announced it has received purchase orders totaling $3M from its lead silicon carbide test and burn-in customer for multiple WaferPak Contactors and a FOX WaferPak Aligner to meet their increased production capacity needs for power semiconductors for the electric vehicle market. This customer is a leading Fortune 500 supplier of semiconductor devices with a significant customer base in the automotive semiconductor market. These WaferPaks and the WaferPak Aligner are expected to ship within the next six months to accompany the previously ordered FOX-XP systems announced last month. Gayn Erickson, President and CEO of Aehr Test Systems, commented, "These follow-on orders for additional WaferPaks and an Aehr WaferPak Aligner signify a strengthening of our relationship with this lead customer to supply them with the high-volume production solution necessary to meet the critical quality and reliability requirements of the electric vehicle power conversion and electronic engine controllers. This customer continues to forecast orders for multiple additional FOX systems and WaferPak Contactors this fiscal year and a significant number of systems and WaferPaks over the next several years driven by electric vehicle semiconductor test and burn-in demand."

07:33 EDT MindMed announces collaboration with Forian - Mind Medicine (MNMD) has agreed to work with Forian (FORA), a leading provider of evidence-based support for more comprehensive clinical and commercial decision-making. MindMed and Forian will collaborate to develop best practices for using real-world evidence information to help improve the health and lives of psychiatric patients. Forian has deep domain experience in RWE and outcomes studies and has developed a variety of information products to serve the healthcare industry.

07:32 EDT Mindset files U.S. provisional patent for DMT/5-MeO-DMT analogs - Mindset Pharma announced that it has filed its new provisional patent application with the United States Patent and Trademark Office extending its Family 4 compounds, a set of novel DMT/5-MeO-DMT analogs. This most recent patent application covers a comprehensive range of next generation drug candidates, their related chemical process synthesis, composition of matter and therapeutic uses. Family 4 compounds are DMT and 5-MeO-DMT inspired drug candidate that offer a broad range of pharmacological diversity suitable for in-clinic settings. The Company has run a battery of specialized in-vitro and in-vivo tests on its patent-pending novel compounds to select the optimal psychedelic drug candidates for progressing towards human clinical trials.

07:31 EDT DraftKings agrees to mult-year deal with Simplebet - Simplebet announced a multi-year agreement with DraftKings to launch real-money micro-betting across the DraftKings Sportsbook. Integration with Simplebet's micro-betting technology will allow DraftKings customers to engage even further with the sports they love by wagering, among other things, play-by-play, throw-by-throw and pitch-by-pitch throughout a sporting event. Under the agreement, DraftKings will be able to offer Simplebet's micro-betting products for the NFL, MLB and NBA and a new suite of college football products, which are the first micro-betting products available for collegiate sports. With micro-betting, DraftKings customers will now be able to wager on even more individual moments over the course of a game through the DraftKings Sportsbook.

07:27 EDT Pinduoduo launches "10 Billion Agriculture Initiative" - Pinduoduo posted a 89% gain in second-quarter revenue as more consumers shopped through the platform. Revenue for the three months ended June 30, 2021 rose to 23.0 billion yuan, the company said in a filing. The number of users who placed orders through Pinduoduo in the trailing 12-month period rose to 849.9 million. Pinduoduo at the same time announced that it would launch a dedicated "10 Billion Agriculture Initiative" to face and address critical needs in the agricultural sector and rural areas. Profits from the second quarter and any potential profits in future quarters would be allocated to the Initiative. The Initiative would not be driven by profit or commercial goals, but strive to facilitate the advancement of agritech, promote digital inclusion, and provide agritech talents and workers with greater motivation and a sense of achievement. Although the "10 Billion Agriculture Initiative" will clearly impact the short-term earnings per share for shareholders, the Initiative has already received the support and approval of the Board of Directors, and will be personally overseen by Chairman and CEO Chen Lei. The company will subsequently convene a shareholders' meeting to seek the support of majority shareholders.

07:10 EDT Delta 9 Cannabis opens thirteenth cannabis store - DELTA 9 CANNABIS announced the grand opening of its thirteenth Delta 9 Cannabis retail store, and tenth cannabis store in the Province of Manitoba. Delta 9's newest retail store is located in the City of Selkirk and is scheduled to open on August 26, 2021.

07:08 EDT First Advantage to host webinar series on state of drug screening - According to a June 2021 report from the American Medical Association, COVID-19 has increased drug abuse. Information from health agencies, law enforcement, emergency medical services, research journals and other sources indicates that every state has experienced a spike in overdoses or related problems during the pandemic. For employers, this is particularly concerning from a workplace safety and productivity perspective, especially in the face of potential regulatory testing changes. During these webinars, First Advantage will explore the state of drug screening and share expert insights to help employers navigate this "new" future. "In the Weeds on Today's Drug Testing Landscape" : On August 31, Josephine Kenney, Chief Global Compliance Officer for First Advantage, will join Bill Current, President and Founder of Current Consulting Group, to discuss the findings of this year's employer drug testing survey conducted by Current's organization. Kenney and Current will examine what's happening now, the leading trends shaping employers' actions and consider how employers can better manage the challenges of today's drug screening landscape. Approved for one continuing education credit hour from SHRM and HRCI. "The New Future of Drug Screening": Recognizing the post-COVID-19 need for a highly digitized approach to recruiting, subject matter experts from First Advantage will deliver a demo of a virtual drug screening technology and explain how a leading retailer streamlined its process using this solution, reducing screening turnaround times and minimizing administrative burden. Session attendees will hear about macro trends in drug testing and compliance, including thoughts and considerations related to marijuana screening, and learn about changes in candidate onboarding expectations, complete with drug screening program suggestions that can help businesses onboard faster and reduce candidate drop-offs. Approved for one continuing education credit hour from SHRM and HRCI.

07:08 EDT Yamana Gold repurchases an additional 1.584M shares for C$18M - Yamana Gold announced that it has repurchased an additional 1,584,500 common shares under the Company's normal course issuer bid for a cumulative total of 3,321,276 common shares for approximately C$18M purchased since the initiation of its share repurchase program for up to 5% of the outstanding shares. The Company plans to be selective and opportunistic in relation to share repurchases intending to enter market when permitted and at times when the trading range of its shares do not reflect the underlying value. The Company believes that the market price of its common shares does not currently represent their full value and growth prospects and views purchases of common shares as an attractive investment comparable to its investments in its portfolio of exploration and development stage assets. The share repurchases are a further component of the Company's capital returns program, which also includes cash returns through the Company's dividends, which have cumulatively increased by 500% since the second quarter of 2019.

07:06 EDT Immunocore says FDA, EMA accept BLA, MAA for tebentafusp in mUM - Immunocore Holdings announces that regulators in the United States and European Union have each accepted applications for the approval of tebentafusp for the treatment of HLA-A 02:01-positive adult patients with metastatic uveal melanoma. The U.S. Food and Drug Administration has accepted for review Immunocore's Biologics License application for tebentafusp. The FDA has granted Priority Review to the Company's BLA submission, a designation for drugs which, if approved, may provide significant improvements in the safety and effectiveness of the treatment of serious conditions. Priority Review designation shortens the review period from the standard ten months to six months from the filing acceptance of the BLA, and therefore, an expected PDUFA target action date of February 23, 2022. The BLA was initiated and will be reviewed under the Real-Time Oncology Review pilot program, an initiative of the FDA's Oncology Center of Excellence which is designed to expedite the delivery of safe and effective cancer treatments to patients. Tebentafusp is also being reviewed under the FDA's Project Orbis initiative, which enables concurrent review by the health authorities in partner countries that have requested participation. Previously, the FDA has granted Breakthrough Therapy Designation to tebentafusp for the treatment of HLA-A 02:01-positive adult patients with unresectable or metastatic uveal melanoma. The European Medicines Agency's Committee for Medicinal Products for Human Use, accepted Immunocore's Marketing Authorization Application. The EMA has also agreed to the Company's request for accelerated assessment of its MAA based on the determination that tebentafusp is a product of major interest for public health and therapeutic innovation. Accelerated assessment potentially reduces the time frame for the CHMP and Committee for Advanced Therapies to review the Company's submitted MAA for advanced therapies. While the CHMP review period of a MAA can take up to 210 days, the accelerated assessment reduces the timeframe for review of the MAA to 150 day. The regulatory submissions are based on data from the randomized Phase 3 IMCgp100-202 clinical trial evaluating tebentafusp in previously untreated metastatic uveal melanoma, a cancer that has historically proven to be frequently insensitive to other immunotherapies. In the final trial analysis, tebentafusp demonstrated clinically and statistically significant superior overall survival benefit as a monotherapy. The primary endpoint was achieved with the OS Hazard Ratio in the intent-to-treat population favoring tebentafusp, HR=0.51 over investigator's choice.

07:04 EDT GuideWell to acquire Triple-S for $900M - GuideWell Mutual Holding, parent of Blue Cross and Blue Shield of Florida, and Triple-S Management, announced they will combine to transform the health care experience for their members in Florida and Puerto Rico. Under the terms of the definitive agreement, GuideWell will acquire all the outstanding shares of Triple-S Management common stock for $36.00 per share in cash, representing a premium of approximately 49% to Triple-S Management's 90-day volume-weighted average trading price. The transaction equity value is approximately $900M. Upon completion of the Transaction, Triple-S Management will become a subsidiary of GuideWell and will continue to operate under the Triple-S Management brand. The agreement was unanimously approved by both companies' Boards of Directors. GuideWell expects the Transaction to be immediately accretive. The Transaction is expected to close in the first half of 2022, subject to satisfaction of normal closing conditions, including customary state and federal regulatory review and approval as well as approval by Triple-S Management shareholders. J.P. Morgan Securities is serving as exclusive financial advisor to GuideWell, and Cravath, Swaine & Moore is serving as legal counsel. Goldman Sachs & Co. is serving as exclusive financial advisor to Triple-S Management, and Davis Polk & Wardell is serving as legal counsel.

07:04 EDT Vertex Pharmaceuticals, Arbr Biotechnologies establish new collaboration - Vertex Pharmaceuticals and Arbor Biotechnologies announced a new collaboration to enhance efforts in developing ex vivo engineered cell therapies, using Arbor's proprietary CRISPR gene-editing technology for select diseases. The new agreement between Arbor and Vertex builds upon the companies' first partnership established in 2018. Under this new partnership, Vertex will receive rights to use Arbor's technology to research and develop ex vivo engineered cell therapies towards Vertex's goal of generating fully differentiated, insulin-producing hypoimmune islet cells for the treatment of type 1 diabetes, for next-generation approaches in sickle cell disease and beta thalassemia, and for the treatment of other diseases. "This new collaboration further expands our toolkit in cell and genetic therapies and, specifically, our work to discover and develop cell therapies for the treatment of multiple serious diseases," said Bastiano Sanna, Ph.D., Executive Vice President and Chief of Cell and Genetic Therapies at Vertex. "We are excited to bring Arbor's technology together with Vertex's ongoing programs and capabilities in diabetes, hemoglobinopathies and other diseases to create improved cell replacement therapies for broad populations of patients."

07:03 EDT Regeneron's ongoing phase 2 trial of 8mg dose of aflibercept met safety endpoint - Regeneron "announced that an ongoing Phase 2 proof-of-concept trial evaluating an investigational 8 mg dose of aflibercept met its primary safety endpoint, with no new safety signals observed compared to the currently-approved 2 mg dose of EYLEA Injection in patients with wet age-related macular degeneration. In this small trial involving 106 patients, a higher proportion of patients in the aflibercept 8 mg group had no retinal fluid compared to patients treated with EYLEA 2 mg at week 16, the primary efficacy endpoint. At this timepoint patients had received three initial doses after which dosing was extended. Aflibercept 8 mg is currently being evaluated in two large Phase 3 trials in wet AMD and diabetic macular edema , which are expected to report results in the second half of 2022. The trials will assess the safety and efficacy of aflibercept 8 mg for up to two years, with visual acuity as the primary efficacy endpoint at 48 weeks, measured by the Early Treatment Diabetic Retinopathy Study Best Corrected Visual Acuity. Both trials will assess aflibercept 8 mg compared to EYLEA 2 mg, testing dosing intervals of every 12 weeks and every 16 weeks. During the initial 16 weeks of the Phase 2 trial, adverse events in the study eye occurred in 17% of aflibercept 8 mg patients and 22.6% of EYLEA 2 mg patients. Serious ocular AEs occurred in two patients overall, one in the aflibercept 8 mg group and one in the EYLEA 2 mg group. There were no AEs of intraocular inflammation, anti-platelet trialists' collaboration-defined arterial thromboembolic events or deaths in either patient group."

07:02 EDT Bio-Path announces clearance of IND for BP1002 - Bio-Path announced that the U.S. Food and Drug Administration has reviewed and cleared the Investigational New Drug, or IND, application for BP1002, the company's second drug candidate, for an initial Phase 1/ 1b clinical trial that will evaluate the ability of BP1002 to treat refractory/relapsed acute myeloid leukemia patients. By targeting Bcl-2 at the DNA level rather than the protein, BP1002 might overcome and prevent some of the mechanisms of resistance that affect venetoclax. The Phase 1/1b clinical trial is anticipated to be conducted at several leading cancer centers in the United States, including the Weill Medical College of Cornell University, The University of Texas MD Anderson Cancer Center and the Georgia Cancer Center. Initially, a total of six evaluable patients are scheduled to be treated with BP1002 monotherapy in a standard 3+3 design, with a starting dose of 20 mg/m2. The approved treatment cycle is two doses per week over four weeks, resulting in eight doses administered over twenty-eight days. The Phase 1b portion of the study will commence after completion of BP1002 monotherapy cohorts and will assess the safety and efficacy of BP1002 in combination with decitabine in refractory/relapsed AML patients. The IND review process was performed by the FDA's Office of Oncologic Diseases, Division of Hematologic Malignancies and involved a comprehensive review of data submitted by the Company covering pre-clinical studies, safety, chemistry, manufacturing and controls, and the protocol for the Phase 1/1b clinical trial

06:52 EDT ViewRay says Amsterdam UMC offers same-day ablative treatment with MRIdian SMART - ViewRay announced that the clinical team at Amsterdam University Medical Centers has started offering "same-day ablative treatment" using MRIdian SMART for patients who are eligible for single fraction MRI-guided radiation therapy. Three patients under treatment for lung tumors were the first to benefit from this program. Typically, patients undergoing radiation therapy are required to make several visits to the hospital from consultation, through planning scan to multiple treatments. This program significantly reduces the burden of multiple trips to the hospital, by combining the initial clinical consultation, simulation, treatment planning and delivery, all within a single visit. At Amsterdam UMC, nearly 50 patients have been treated with a single ablative fraction on the MRIdian. By optimizing departmental logistics, the Amsterdam UMC team consolidates the patient treatment planning activities, including a single fraction treatment into a single visit. In addition to lung, Amsterdam UMC is extending this same-day ablative treatment service to adrenal, renal and other tumor sites.

06:48 EDT NGL Energy Partners names Linda Bridges as CFO - NGL Energy Partner announces that Linda Bridges will be promoted to Executive Vice President and CFO effective September 30 and will be reporting to H. Michael Krimbill, the Partnership's CEO. Bridges joined the Partnership in June 2016 as the Partnership's Vice President of Finance and Treasurer and was promoted to Senior Vice President of Finance and Treasurer in April 2018. Prior to joining the Partnership, Bridges spent nine years in the commercial division at Bank of Oklahoma, primarily as a lender to both upstream and midstream energy clients. Robert Karlovich III has announced that he will be resigning from his position with the Partnership effective September 30 to pursue personal business interests.

06:46 EDT IAA names Susan Healy as CFO, succeeding Vance Johnston - IAA announces that effective September 1, Susan Healy will join the company as executive vice president and CFO. Healy is a finance and Wall Street veteran with more than 25 years of experience driving growth and operational improvement at a number of highly respected, multinational companies. Healy will succeed Vance Johnston, who is leaving IAA to pursue other opportunities.

06:37 EDT Advance Auto Parts CEO says Q2 results led by professional business - "Advance's second quarter results highlight the strength of our team and diversified asset base as we continue to make progress on our long-term strategic objectives," said Tom Greco, president and CEO. "I'd like to thank all our team members and independent partners for their relentless focus on execution. In the second quarter, we delivered a 5.8% increase in comparable store sales and 13.3% on a two-year stack. Our top-line improvement was led by the professional business with a recovery in miles driven fueling demand as we lapped double-digit DIY omnichannel growth in the prior year. Our Adjusted operating income margin expanded 11 basis points to 11.4%. When compared with the second quarter of 2019, our Adjusted operating income margin increased 227 basis points demonstrating progress against our margin expansion initiatives. Adjusted diluted EPS increased 15.3% to $3.40 compared with the second quarter of 2020 and increased 56.7% compared with 2019. Our commitment to improving working capital and protecting our balance sheet throughout the pandemic enabled a more than doubling of our Free cash flow when compared with the same period of 2020. Year to date through the second quarter of 2021, Free cash flow of $646.6 million, increased 70% versus the same period of 2019."

06:35 EDT Hexo completes transfer of its stock exchange listing to Nasdaq Capital Market - HEXO announced that the previously announced transfer of its stock exchange listing to the Nasdaq Capital Market from the New York Stock Exchange is complete. The Company's common share will begin trading as a Nasdaq-listed security at market open today, August 24. Current retail and institutional investor shares will automatically be transferred over to Nasdaq. Current shareholders are not required to take any action.

06:34 EDT Advance Auto Parts raises FY21 free cash flow view to minimum of $700M - Prior view was minimum of $575M. Raises FY21 share repurchase view to $700M-$900M from $300M-$500M. Sees FY21 new store openings 80-120 vs. prior view of 100-150.

06:33 EDT Phoenix New Media enters new program license agreement with Phoenix TV - Phoenix New Media announced that it has, through one of its affiliated consolidated entities, entered into a new program resource license and cooperation agreement with a subsidiary of its parent company, Phoenix Satellite Television and terminate the existing program resource license and cooperation agreement between the parties entered into on January 15, 2020. According to the 2021 program license agreement, Phoenix TV grants the licensee exclusive right to broadcast copyrighted video content and the derived audio content from three television channels of Phoenix TV and its subsidiaries on the internet in Mainland China with such content also broadcasted on the three television channels of Phoenix TV and its subsidiaries. Phoenix TV also grants the licensee the right to sublicense such contents. The annual fees payable to Phoenix TV by the company for such content licenses will be RMB 45M and the 2021 program license agreement has a term of three years.

06:15 EDT Correct: Outfront Media downgraded to Equal Weight at Morgan Stanley previously

06:01 EDT Maxar Technologies receives order for new communications satellite from SiriusXM - Maxar Technologies announced it received an order to build another geostationary communications satellite for longtime customer SiriusXM, following the SXM-9 satellite order that was announced earlier this month. SXM-10, a high-powered digital audio radio satellite, will be built on Maxar's proven 1300-class platform at the company's manufacturing facility in Palo Alto, California.

05:32 EDT Walmart launches GoLocal delivery as a service business - Walmart announced the creation of a new line of business - Walmart GoLocal - that extends its expertise in delivering goods to customers to businesses of all sizes. Walmart GoLocal is built on the retailer's ability to execute delivery capabilities at scale. In just three years, the retailer launched and scaled delivery and express delivery for its customers on 160,000+ items from more than 3,000 stores, reaching nearly 70% of the U.S. population and growing using its existing delivery network, including drones, autonomous vehicles and market fulfillment centers. The business will also rapidly expand to offer additional offerings. Walmart GoLocal has already established a number of contractual agreements with national and enterprise retail clients and is currently accepting select new merchant partners.

05:27 EDT Cara Therapeutics, Vifor Pharma receives FDA approval for Korsuva - Vifor Pharma (GNHAF) and Cara Therapeutics (CARA) announced that the FDA has approved Korsuva for injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease in adults undergoing hemodialysis. Korsuva injection is a first-in-class kappa opioid receptor, or KOR, agonist that targets the body's peripheral nervous system. The Korsuva injection new drug application, or NDA, received Priority Review by the FDA, which is granted to therapies that, if approved, would offer significant improvements in the safety or effectiveness of the treatment, diagnosis, or prevention of serious conditions when compared to standard applications. Vifor Pharma and Cara Therapeutics are in the process of submitting the required documentation to the U.S. Centers for Medicare and Medicaid Services, or CMS, to ensure timely reimbursement and patient access to Korsuva injection. Vifor Pharma expects to begin to market Korsuva injection in Q1 2022 with reimbursement expected in H1 2022, subject to CMS timelines.

05:11 EDT Clovis announces Rubraca availability, reimbursement eligibility in Switzerland - Clovis announced that Rubraca is now available and reimbursed in Switzerland. The Swiss authority responsible for the authorization and supervision of therapeutic products gave a recommendation for Rubraca as maintenance treatment for recurrent platinum sensitive ovarian cancer. Rubraca is indicated for eligible patients regardless of BRCA status, which means it can be prescribed for women who harbor a BRCA mutation or who are BRCA wild-type.

05:06 EDT Visa announces partnership in Asia Pacific with Ascenda - Visa announced a strategic partnership in Asia Pacific with Ascenda, the loyalty technology company. The payments network will be first globally to leverage Ascenda's new Nexus platform, which will enable Visa's partners to adopt a new rewards program for their customers. The Visa-Ascenda rewards solution is being rolled out progressively across Asia Pacific.